Doxercalciferol - CAS 54573-75-0
Catalog number: 54573-75-0
Category: Inhibitor
Not Intended for Therapeutic Use. For research use only.
COA:
Inquire
Targets:
VD/VDR
Description:
Doxercalciferol (Hectorol; 1.alpha.-Hydroxyvitamin D2) is a synthetic analog of vitamin D; is a Vitamin D2 analog that acts as a vitamin D receptor activator (VDRA).
Publictions citing BOC Sciences Products
  • >> More
Purity:
0.98
Synonyms:
Hectorol; 1.alpha.-Hydroxyvitamin D2.
MSDS:
Inquire
1.Calcium regulates FGF-23 expression in bone.
David V1, Dai B, Martin A, Huang J, Han X, Quarles LD. Endocrinology. 2013 Dec;154(12):4469-82. doi: 10.1210/en.2013-1627. Epub 2013 Oct 18.
Calcium has recently been shown to regulate fibroblast growth factor 23 (FGF-23), a bone-derived phosphate and vitamin D-regulating hormone. To better understand the regulation of FGF-23 by calcium, phosphorus, 1,25 dihydroxyvitamin D3 [1,25(OH)2D], and PTH, we examined FGF-23 expression under basal conditions and in response to PTH, doxercalciferol, or high-calcium diet treatment in Gcm2(-/-) and Cyp27b1(-/-) mutant mice. Gcm2(-/-) mice exhibited low serum PTH and 1,25(OH)2D concentrations, hypocalcemia, and hyperphosphatemia, whereas Cyp27b1(-/-) mice had high PTH, undetectable 1,25(OH)2D, hypocalcemia, and hypophosphatemia. Serum FGF-23 levels were decreased in both mutant models. Doxercalciferol administration increased serum FGF-23 levels in both mutant models. PTH administration to Gcm2(-/-) mice also increased serum FGF-23 levels, in association with an increase in both 1,25(OH)2D and calcium concentrations. Multiple regression analysis of pooled data indicated that changes in FGF-23 were positively correlated with serum calcium and 1,25(OH)2D but not related to changes in serum phosphate concentrations.
2.Effect of Vitamin D Receptor Activators on Glomerular Filtration Rate: A Meta-Analysis and Systematic Review.
Zhang Q1, Li M2, Zhang T3, Chen J4. PLoS One. 2016 Jan 26;11(1):e0147347. doi: 10.1371/journal.pone.0147347. eCollection 2016.
BACKGROUND: Vitamin D receptor activators (VDRAs) can protect against mineral bone disease, but they are reported to elevate serum creatinine (SCr) and may also reduce glomerular filtration rate (GFR).
3.Interventions for metabolic bone disease in children with chronic kidney disease.
Hahn D1, Hodson EM, Craig JC. Cochrane Database Syst Rev. 2015 Nov 12;11:CD008327. doi: 10.1002/14651858.CD008327.pub2.
BACKGROUND: Bone disease is common in children with chronic kidney disease (CKD) and when untreated may result in bone deformities, bone pain, fractures and reduced growth rates. This is an update of a review first published in 2010.
4.Osteocytic protein expression response to doxercalciferol therapy in pediatric dialysis patients.
Pereira RC1, Jüppner H2, Gales B1, Salusky IB1, Wesseling-Perry K1. PLoS One. 2015 Mar 16;10(3):e0120856. doi: 10.1371/journal.pone.0120856. eCollection 2015.
BACKGROUND: Osteocytic protein expression is dysregulated in CKD and is affected by changes in mineral metabolism; however the effects of active vitamin D sterol therapy on osteocyte protein expression in advanced CKD is unknown.
Molecular Weight Calculator Molarity Calculator Solution Dilution Calculator

Related VD/VDR Products


CAS 129831-99-8 MC 976

MC 976
(CAS: 129831-99-8)

MC 969 is an analog of the calcemic drug 1α-hydroxyvitamin D3 (1α-OH-D3) in which carbons 25, 26, and 27 in the side chain are incorporated into a cyclopropane ...

CAS 143032-85-3 1α-Hydroxy VD4

1α-Hydroxy VD4
(CAS: 143032-85-3)

1alpha-Hydroxy VD4 , a 1alpha(OH)D derivative,  can effectively induce the differentiation of monoblastic leukaemia U937, P39/TSU and P31/FUJ cells.

CAS 55700-58-8 (24S)-24,25-Dihydroxyvitamin D3

(24S)-24,25-Dihydroxyvitamin D3
(CAS: 55700-58-8)

(24S)-24,25-Dihydroxycholecalciferol is an inactive form of vitamin D3 which undergoes various levels of hydroxylation to form active vitamin D3 analogs.

CAS 131918-61-1 Paricalcitol

Paricalcitol
(CAS: 131918-61-1)

Synthetic analog of vitamin D. Antihyperparathyroid.

CAS 83805-11-2 Falecalcitriol

Falecalcitriol
(CAS: 83805-11-2)

Falecalcitriol is an analog of calcitriol. It has a higher potency both in vivo and in vitro systems, and longer duration of action in vivo.

CAS 72203-93-1 Calcitetrol

Calcitetrol
(CAS: 72203-93-1)

Calcitetrol is the hormonally active form of vitamin D with three hydroxyl groups. It increases blood calcium levels ([Ca2+]) by promoting absorption of dietary...

CAS 54573-75-0 Doxercalciferol

Doxercalciferol
(CAS: 54573-75-0)

Doxercalciferol (Hectorol; 1.alpha.-Hydroxyvitamin D2) is a synthetic analog of vitamin D; is a Vitamin D2 analog that acts as a vitamin D receptor activator (V...

CAS 104121-92-8 Eldecalcitol

Eldecalcitol
(CAS: 104121-92-8)

Eldecalcitol, a vitamin D analog, has strong effects to reduce calcium reabsorption into the body from bones, therefore increasing bone mineral density, and to ...

CAS 40013-87-4 24, 25-Dihydroxy VD3

24, 25-Dihydroxy VD3
(CAS: 40013-87-4)

24, 25-Dihydroxy VD3 is a compound which is closely related to 1,25-dihydroxyvitamin D3, the active form of vitamin D3, but like vitamin D3 itself and 25-hydrox...

CAS 60133-18-8 Ercalcitriol

Ercalcitriol
(CAS: 60133-18-8)

Ercalcitriol is a active metabolite of vitamin D2. It exhibits equipotent antirachitic activity in rats as calcitriol.

CAS 41294-56-8 Alfacalcidol

Alfacalcidol
(CAS: 41294-56-8)

A synthetic analog of Calcitiol (the hormonal form of vitamin D3), which shows identical potency with respect to stimulation of intestinal calcium absorption an...

CAS 19356-17-3 Calcifediol

Calcifediol
(CAS: 19356-17-3)

Calcifediol is a major circulating metabolite of vitamin D3 and acts as a competitive inhibitor with an apparent Ki of 3.9 μM. It also suppresses PTH secretion ...

CAS 63283-36-3 Calcifediol monohydrate

Calcifediol monohydrate
(CAS: 63283-36-3)

Calcifediol monohydrate is a prehormone that is produced in the liver by hydroxylation of vitamin D3 (cholecalciferol) by the enzyme cholecalciferol 25-hydroxyl...

CAS 82266-85-1 Impurity C of Alfacalcidol

Impurity C of Alfacalcidol
(CAS: 82266-85-1)

Impurity C of Alfacalcidol is impurity of Alfacalcidol, which is a non-selective VDR activator medication. Alfacalcidol improves mechanical bone strength and bo...

CAS 199798-84-0 BXL 628

BXL 628
(CAS: 199798-84-0)

BXL 628 is a vitamin D3 analogue that competes with vitamin D receptor (VDR) for inhibition of prostate cell growth and RhoA/Rho-kinase signaling, a calcium sen...

CAS 93129-94-3 Tacalcitol monohydrate

Tacalcitol monohydrate
(CAS: 93129-94-3)

Tacalcitol monohydrate is a VDR-like Receptor promotes normal bone development by regulating calcium. It modulates immunological and inflammatory processes and ...

CAS 50-14-6 Vitamin D2

Vitamin D2
(CAS: 50-14-6)

Vitamin D2 is a selective inhibitor of mammalian DNA polymerase A (pol A) with IC50 of 123 mM.

CAS 112827-99-3 24R-Calcipotriol

24R-Calcipotriol
(CAS: 112827-99-3)

24R-Calcipotriol is an impurity of Calcipotriol, which is a ligand of VDR-like receptors.

CAS 58050-55-8 24, 25-Dihydroxy VD2

24, 25-Dihydroxy VD2
(CAS: 58050-55-8)

24, 25-Dihydroxy VD2 is a hydroxylated metabolite of Vitamin D2, which is a synthetic analog of Vitamin D.

CAS 112965-21-6 Calcipotriol

Calcipotriol
(CAS: 112965-21-6)

Calcipotriol, a 1,25-Dihydroxyvitamin D3 analogue, is used as topical treatment for psoriasis.

Chemical Structure

CAS 54573-75-0 Doxercalciferol

Quick Inquiry

Verification code

Featured Items